Filing Flows › 10x Genomics (TXG) › Guidance history
10x Genomics (TXG) guidance history: what it guided and what it reported
10x Genomics gave guidance in 12 earnings releases on file since Feb 15, 2024. Of 5 guided periods since reported, it met or beat its own guidance 5 times (100%). Revenue: 5 of 5, on average +8.1% against the guided midpoint. Its releases raised guidance twice and lowered it twice.
Revenue
Met or beat 5 of 5 periods (5 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $600M–$625M (Feb 12, 2026) → reaffirmed $600M–$625M (May 7, 2026) → raised $610M–$630M (Aug 6, 2026) → raised $625M–$635M (Nov 5, 2026) | — | to be reported | — |
| Q4 2025 | $154M–$158M (Nov 6, 2025) | $166M | above the range | +6.4% |
| FY2025 | $610M–$630M (Feb 12, 2025) | $643M | above the range | +3.7% |
| Q3 2025 | $140M–$144M (Aug 7, 2025) | $149M | above the range | +4.9% |
| Q2 2025 | $138M–$142M (May 8, 2025) | $173M | above the range | +23.5% |
| FY2024 | $670M–$690M (Feb 15, 2024) → reaffirmed $670M–$690M (Apr 30, 2024) → lowered $640M–$660M (Aug 8, 2024) → lowered $595M–$605M (Oct 29, 2024) | $611M | above the range | +1.8% |
Operating expenses
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2025 | $50.0M (May 8, 2025) | — | — | — |
The latest quarter
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Questions
Does 10x Genomics beat its guidance?
10x Genomics gave guidance in 12 earnings releases on file since Feb 15, 2024. Of 5 guided periods since reported, it met or beat its own guidance 5 times (100%). Revenue: 5 of 5, on average +8.1% against the guided midpoint.
How often does 10x Genomics raise guidance?
Its earnings releases raised guidance twice and lowered it twice since Feb 15, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.